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Abstract
Objective We systematically reviewed the evidence of an
association between male circumcision and penile cancer.
Methods Databases were searched using keywords and
text terms for the epidemiology of penile cancer. Random
effects meta-analyses were used to calculate summary odds
ratios (ORs) and 95% conﬁdence intervals (CI).
Results We identiﬁed eight papers which evaluated the
association of circumcision with penile cancer, of which
seven were case–control studies. There was a strong pro-
tective effect of childhood/adolescent circumcision on
invasive penile cancer (OR = 0.33; 95% CI 0.13–0.83; 3
studies). In two studies, the protective effect of childhood/
adolescent circumcision on invasive cancer no longer
persisted when analyses were restricted to boys with no
history of phimosis.
In contrast, there was some evidence that circumcision in
adulthood was associated with an increased risk of invasive
penile cancer (summary OR = 2.71; 95% CI 0.93–7.94; 3
studies). There was little evidence for an association of
penile intra-epithelial neoplasia and in situ penile cancer
with circumcision performed at any age.
Conclusions Men circumcised in childhood/adolescence
are at substantially reduced risk of invasive penile cancer,
and this effect could be mediated partly through an effect
on phimosis. Expansion of circumcision services in sub-
Saharan Africa as an HIV prevention strategy may addi-
tionally reduce penile cancer risk.
Keywords Penile neoplasms  Male circumcision 
Phimosis  Papillomavirus infections
Introduction
Penile cancer is relatively rare globally with an annual
incidence of less than 1 case per 100,000 person-years
(pyr) in Western countries [1]. However, recorded inci-
dences are higher in many countries in sub-Saharan
Africa including Uganda (2.7/100,000 pyr), Swaziland
(3.2/100,000 pyr) and Zimbabwe (1.6/100,000 pyr) [2–5].
Similarly, although penile cancer accounts for less than
0.5% of cancers in men globally, it accounts for a relatively
higher proportion of cancers in Swaziland (4.4%), Rwanda
(2.9%), Kenya (1.9%) and Uganda (1.7%) [2, 3, 6].
Penile cancer typically occurs in later life (median age at
diagnosis in the United States of America (USA) is
68 years) [7]. Other factors associated with increased risk
of penile cancer include low socio-economic status, ciga-
rette smoking, human papillomavirus (HPV) infection, lack
of penile hygiene, phimosis and penile inﬂammation [8].
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penile cancer was in 1932, when, among 1,103 penile
cancer cases in the USA, none were Jewish despite 3% of
the population being Jewish (and hence circumcised) [9].
Subsequent case series also showed a lower than expected
prevalence of neonatal circumcision among penile cancer
cases [10–12].
Ecological evidence came from studies in East Africa in
the 1960s which showed that penile cancer was more
common than expected in traditionally non-circumcising
ethnic groups than among traditionally circumcising ethnic
groups [6, 13]. The ﬁrst case–control study of penile can-
cer, published in 1947 among American military personnel,
showed that circumcision in childhood was rare among
cases of penile cancer compared to controls (1.5% vs.
17.8%; OR = 0.07, 95% CI 0.01–0.28) [14].
Although male circumcision is widely cited to protect
against penile cancer [15–19], the epidemiological evi-
dence has never been systematically evaluated. Circumci-
sion services are currently being expanded for HIV
prevention in several African countries [20], and as penile
cancer incidence is relatively high in many of these
countries, expansion of circumcision services may provide
an opportunity to reduce incidence of penile cancer.
The aim of this paper is to systematically review and
summarise the epidemiological evidence of an association
between male circumcision and penile intraepithelial neo-
plasia (PIN), in situ and invasive penile cancer, and to
discuss the possible mechanisms and biological pathways
for the association.
Materials and methods
Search strategy
Pubmed and Embase databases were searched on 22 April
2009 and updated on 15 September 2010 (for search terms
see Box 1). No language restrictions were imposed. We did
not include circumcision in the search terms to avoid
detection bias. We also searched reference lists of relevant
papers. Where information was missing from published
papers, we contacted authors to obtain relevant
information.
All abstracts were reviewed independently by two
authors (NL and HW). Epidemiological studies likely to
contain information on risk factors for penile cancer were
deemed potentially relevant. Agreement about potential
Box 1 Search terms used in PubMed
Search 1
(‘‘Papillomavirus Infections/epidemiology’’[MeSH] OR ‘‘Papillomavirus Infections/etiology’’[MeSH] OR ‘‘Papillomavirus Infections/
prevention and control’’[MeSH] OR ‘‘Papillomavirus Infections/transmission’’[MeSH] OR ‘‘Papillomaviridae’’[MeSH] OR ‘‘Condylomata
Acuminata/epidemiology’’[Mesh] OR ‘‘Condylomata Acuminata/etiology’’[Mesh] OR ‘‘Condylomata Acuminata/prevention and
control’’[Mesh] OR ‘‘Condylomata Acuminata/transmission’’[Mesh] OR ‘‘Warts/epidemiology’’[Mesh] OR ‘‘Warts/etiology’’[Mesh] OR
‘‘Warts/prevention and control’’[Mesh] OR ‘‘Warts/transmission’’[Mesh]OR wart*[text word] OR ‘‘papilloma virus’’[text] OR ‘‘papilloma
viruses’’[text word] OR ‘‘HPV’’[text] OR ‘‘condyloma acuminata’’[text word] OR ‘‘condyloma acuminatum’’[text word] OR
papillomavir*[text word] OR ‘‘Penile Neoplasms/epidemiology’’[Mesh] OR ‘‘Penile Neoplasms/etiology’’[Mesh] OR ‘‘Penile Neoplasms/
prevention and control’’[Mesh] OR ‘‘Penile Neoplasms/transmission’’[Mesh] OR ((penil*[text] OR penis*[text]) AND (carcinoma*[text]
OR cancer*[text] OR tumour [text] OR tumor [text] OR tumours[text] OR tumors[text] OR neoplas*[text] OR ‘‘Bowen’s disease’’[text] OR
‘‘Bowen disease’’[text])) OR ‘‘Bowenoid Papulosis’’[text] OR ‘‘Buschke-Lowenstein’’[text] OR ‘‘Buschke Lowenstein’’[text] OR
‘‘erythroplasia of Queyrat’’[text]) AND (‘‘Genital Diseases, Male/epidemiology’’[Mesh] OR ‘‘Genital Diseases, Male/etiology’’[Mesh] OR
‘‘Genital Diseases, Male/transmission’’[Mesh] OR ‘‘Genital Diseases, Male/prevention and control’’[Mesh] OR ‘‘Penile Diseases’’[Mesh]
OR ‘‘Sexually Transmitted Diseases, Viral/epidemiology’’[Mesh] OR ‘‘Sexually Transmitted Diseases, Viral/etiology’’[Mesh] OR
‘‘Sexually Transmitted Diseases, Viral/prevention and control’’[Mesh] OR ‘‘Sexually Transmitted Diseases, Viral/transmission’’[Mesh] OR
‘‘Genitalia, Male’’[Mesh] OR Genital*[Text] OR penil*[text] OR penis*[text] OR scrot*[text] OR anogenital*[text] OR ano-genital*[text]
OR urethra*[text] OR perine*[text]) AND (‘‘Epidemiologic Studies’’[MeSH] OR ‘‘Risk Factors’’[MeSH] OR ‘‘Odds Ratio’’[MeSH] OR
‘‘Prevalence’’[MeSH] OR ‘‘Incidence’’[MeSH] OR ‘‘logistic models’’[MeSH] OR ‘‘multivariate analysis’’[MeSH] OR prevalence[Text
Word] OR incidence[Text Word] OR ‘‘odds ratio’’[Text Word] OR ‘‘risk ratio’’[Text Word] OR ‘‘risk factor’’[Text Word] OR ‘‘relative
risk’’[Text Word] OR rate*[text]) AND ((Journal Article[pt] OR Letter[pt]) NOT ‘‘Case Reports’’ [Publication Type]) AND
‘‘Humans’’[MeSH Terms] AND (‘‘Male’’[MeSH] OR Male [Text] OR Males[Text])
Search 2 (excluding articles from search 1)
(‘‘Papillomavirus Infections/epidemiology’’[MeSH] OR ‘‘Condylomata Acuminata/epidemiology’’[Mesh] OR ‘‘Warts/epidemiology’’[Mesh]
OR ‘‘Penile Neoplasms/epidemiology’’[Mesh]) AND (‘‘Genital Diseases, Male/epidemiology’’[Mesh] OR ‘‘Genital Diseases, Male/
etiology’’[Mesh] OR ‘‘Genital Diseases, Male/transmission’’[Mesh] OR ‘‘Genital Diseases, Male/prevention and control’’[Mesh] OR
‘‘Penile Diseases’’[Mesh] OR ‘‘Sexually Transmitted Diseases, Viral/epidemiology’’[Mesh] OR ‘‘Sexually Transmitted Diseases, Viral/
etiology’’[Mesh] OR ‘‘Sexually Transmitted Diseases, Viral/prevention and control’’[Mesh] OR ‘‘Sexually Transmitted Diseases, Viral/
transmission’’[Mesh] OR ‘‘Genitalia, Male’’[Mesh] OR Genital*[Text] OR penil*[text] OR penis*[text] OR scrot*[text] OR
anogenital*[text] OR ano-genital*[text] OR urethra*[text] OR perine*[text]) AND ((Journal Article[pt] OR Letter[pt]) NOT ‘‘Case
Reports’’ [Publication Type]) AND ‘‘Humans’’[MeSH Terms] AND (‘‘Male’’[MeSH] OR Male [Text] OR Males[Text])
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123relevance was reached by consensus, and full text copies of
those papers were obtained.
Outcome deﬁnition
Penile cancer included penile intra-epithelial neoplasia
(PIN), in situ and invasive penile cancer. As in situ and
invasive penile cancer may develop along different path-
ways [21, 22], and several studies have indicated that the
effect of circumcision may vary depending on the stage of
penile cancer [23–25], we decided a priori to analyse the
effect of circumcision on (1) high-grade PIN and in situ
penile cancer and (2) invasive penile cancer separately.
Data extraction
Data were extracted independently by two authors (NL and
HW) using a standardised pre-piloted data extraction form.
Inconsistencies were discussed by both reviewers and
consensus reached.
Study populations described in more than one paper
were included only once, using data from the paper with
most information on the study methods.
Methodological quality of included studies
Seven quality domains were identiﬁed for case–control
studies and six for cross-sectional studies (see supple-
mentary material). We adopted an approach similar to that
used by the Cochrane Collaboration for assessing risk of
bias in randomised studies [26] and studies were classiﬁed
as having either a high, low, or an unclear (where data were
not reported) risk of bias for each quality domain. Speciﬁc
criteria for assessing risk of bias are included in the sup-
plementary material; of note where 20% or more identiﬁed
prevalent cases could not be contacted, studies were con-
sidered to be at high risk of length bias (survival bias). This
can occur when prevalent cases are missing because they
are too ill to participate or have died, so the included cases
represent those with less aggressive/advanced disease. If
the exposure (i.e. circumcision) has a differential effect
on different stages of disease then length bias may be
introduced.
Two authors (NL and HW) reviewed the quality of
individual studies, and inconsistencies were discussed by
both reviewers and consensus reached.
Data analysis
The effect of circumcision on penile cancer was estimated
using odds ratios (OR). Where ORs were not presented,
crude ORs and 95% CI were calculated from the data when
possible, using exact methods. For each study, the effect
estimate was calculated as the adjusted estimate where
present and the crude estimate otherwise. This best avail-
able estimate was included in a random effects meta-
analysis, using Stata 11. The meta-analysis included (1)
analyses of circumcised men compared to men never cir-
cumcised, and (2) analyses in which the temporality
between circumcision procedure and cancer diagnosis were
deﬁned (assuming that circumcision before the age of
18 years preceded penile cancer).
Circumcision at older ages may have been in response to
penile cancer or pre-cancerous conditions, and a priori
deﬁned subgroup analyses were conducted to compare the
association by age at circumcision.
Phimosis is a condition occurring most commonly in
young boys where the foreskin cannot be fully retracted
over the glans and is a risk factor for penile cancer [8, 23,
24, 27, 28]. Neonatal circumcision eliminates the risk of
phimosis. Phimosis may be on the causal pathway between
circumcision and penile cancer, so we deﬁned a priori a
subgroup analysis of the effect of circumcision on penile
cancer among patients with no history of phimosis.
Summary estimates from sub-groups were formally
compared using meta-regression. Heterogeneity was eval-
uated using the I
2 statistic and the P-value for heteroge-
neity [29]. The I
2 statistic represents the percentage of
between-study variation that is due to heterogeneity rather
than chance.
To address methodological concerns, we planned sen-
sitivity analyses, which restricted analyses to: (1) studies
which adjusted for covariates and (2) studies which
ascertained circumcision status by clinical exam. How-
ever, due to the small number of eligible studies identiﬁed,
only the sensitivity analysis of adjusted analyses with
invasive penile cancer as the outcome could be conducted.
For studies where age at circumcision was not adequately
reported, sensitivity analyses were performed including
them in meta-analyses of the most likely age at circum-
cision, based on information in the paper concerning the
age at circumcision among cases or previously published
data.
Results
Results of search strategy
A total of 3,366 papers were identiﬁed from the database
searches and the full text was obtained for 306 of these
(Fig. 1). A total of 269 papers were excluded based on the
full text, including two studies that compared the preva-
lence of circumcision among cases of invasive penile car-
cinoma with cases of in situ penile cancer. An additional
six papers were identiﬁed from references and review
Cancer Causes Control (2011) 22:1097–1110 1099
123papers. Eight eligible papers were identiﬁed which inclu-
ded information on penile cancer.
Description of eligible papers
The eight papers evaluating the effect of circumcision on
penile cancer included one cross-sectional study and seven
case–control studies (Table 1). Study populations were
from Europe (n = 4), the United States (n = 3), and China
(n = 1).
Age at circumcision was categorised into three groups:
childhood/adolescence (all participants\18 years);
mostly adults (median age C 18 years; minimum 10 years
old); and age inadequately reported (Table 1). The pro-
portion of men circumcised during childhood/adolescence
ranged from 4% in Denmark [28] to 61% in the United
States [23]. Circumcision among adults ranged from 0.7%
in China [27] to 5% in the USA [23].
Five papers evaluated the effect of circumcision on PIN
and/or in situ cancer [23, 24, 28, 30, 31] and six papers
evaluated the effect on invasive cancer [14, 23, 24, 27, 28,
32] (Fig. 1; Table 1).
Quality of studies
One study had ﬁve quality domains classiﬁed as low risk
and two domains classiﬁed as unclear risk [27]; all other
studies had a high risk of bias in one or more of the quality
domains (Table 2).
The potential for length bias was considered to be high
for three case–control studies, where prevalent cases were
identiﬁed and C20% could not be contacted for an inter-
view [23, 24, 28] and unclear in one other study [14]
(Table 2). For these studies, the proportion that were
known to have died between diagnosis and the time of the
study was 13% [23], 17% [24] and 34–38% [28].
The risk of bias from poor participation was low for only
one study [27] (Table 2). Fewer than 80% of identiﬁed
subjects agreed to participate for three studies [23, 24, 28]
and for one of these, the proportion that agreed to partic-
ipate was substantially higher for controls (60%) compared
to cases (27%) [28]. Information on participation was not
available in three studies [30–32].
In four studies, the age at circumcision was not reported
or incompletely reported, [24, 30–32] and the temporality
Fig. 1 Flow chart of study selection for inclusion in the systematic
review.
§3 papers evaluated the effect of circumcision on both in situ
and invasive penile cancer.
The search was conducted as part of a
wider search strategy to identify papers on the association of male
circumcision with HPV, genital warts and penile cancer
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123of any observed association between circumcision and
penile cancer could not be assessed. In a ﬁfth study [27],
although the exact age at circumcision was not reported,
the authors report that none of the boys were circumcised at
birth and all participants were circumcised more than
5 years prior to the study. A high risk of confounding was
present in three studies that did not adjust for age in either
the study design or analysis [14, 30, 31].
Association between circumcision and penile cancer
Penile intra-epithelial neoplasia and in situ penile Cancer
Seven analyses evaluated the association of circumcision
on PIN and in situ penile cancer [23, 24, 28, 30, 31]
(Table 1; Fig. 1).
One of the three analyses of circumcision in childhood/
adolescence and PIN or in situ penile cancer compared men
circumcised in childhood/adolescence with men not cir-
cumcised in childhood/adolescence [28] and was thus
excluded from the meta-analysis. In this study, there were
no penile cancer cases among men circumcised in child-
hood/adolescence, but the 95% CI was wide (OR = 0.00,
95% CI 0.00–5.96). The remaining two analyses were
deemed at low risk of bias from confounding in our quality
assessment. These showed little evidence of an association
of circumcision with PIN and in situ penile cancer (sum-
mary OR = 0.93, 95% CI 0.59–1.47; p-heterogene-
ity = 0.86; I
2 = 0.0%) (Fig. 2). The OR from the single
analysis among men circumcised mostly as adults was
smaller (OR = 0.53; 95% CI 0.06–2.28) but conﬁdence
intervals were wide, and there was little evidence of a
difference in this effect estimate and the summary estimate
for those circumcised in childhood/adolescence (p = 0.60).
Three analyses did not adequately report age at cir-
cumcision. For one (a cross-sectional study from France),
circumcision was likely to have occurred in childhood and
this showed some evidence of a protective effect of cir-
cumcision on PIN and in situ penile cancer (OR = 0.56;
95% CI 0.30–1.00) [30]. A sensitivity analysis including
this analysis with the other analyses of childhood/adoles-
cent circumcision provided only weak evidence of a pro-
tective effect on PIN/in situ penile cancer (summary
OR = 0.77; 95% CI 0.54–1.11 p-heterogeneity = 0.42;
I
2 = 0.0%; n = 3).
Invasive penile cancer
Nine analyses from six papers evaluated the effect of cir-
cumcision on invasive penile cancer [14, 23, 24, 27, 28,
32]; (Table 1; Fig. 1). Three of the four analyses of cir-
cumcision in childhood/adolescence, used a comparison
group of never circumcised men. The overall OR from
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123these three analyses showed strong evidence of a protective
effect (summary OR = 0.33; 95% CI 0.13–0.83) (Fig. 3).
There was some evidence of heterogeneity in estimates
(p-heterogeneity = 0.11; I
2 = 55%) although all three
studies showed a protective rather than detrimental effect.
The sensitivity analysis including only the two analyses
that adjusted for covariates showed little evidence of
heterogeneity (summary OR = 0.50; 95% CI 0.29–0.86;
p-heterogeneity = 0.69; I
2 = 0.0%; n = 2).
The relationship was reversed for analyses of men cir-
cumcised mostly as adults (summary OR = 2.71; 95% CI
0.93–7.94; p-heterogeneity = 0.15; I
2 = 48%; 3 analyses).
Fig. 2 Association of male
circumcision and PIN (I–III)
or in situ penile carcinoma:
random effects meta-analysis
Fig. 3 Association of male
circumcision and invasive
penile carcinoma: random
effects meta-analysis
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123Two analyses inadequately reported the age at circum-
cision and neither provided evidence of a protective effect
of circumcision on invasive cancer (Table 1; Fig. 3). In
one of these analyses, from a case–control study from the
UK, the one cancer patient who was circumcised had been
circumcised in childhood, and the controls are also likely to
have been circumcised during childhood [32]. Including
this analysis in the summary estimate for childhood/ado-
lescent circumcisions gave similar results (summary
OR = 0.36; 95% CI 0.17–0.75; n = 4) to the overall
summary at these ages (OR = 0.33; 95% CI 0.13–0.83;
n = 3) with less heterogeneity in estimates (p-heteroge-
neity = 0.22; I
2 = 32% vs. p-heterogeneity = 0.11;
I
2 = 55%).
For the two analyses [23, 24] which assessed the effect
of childhood/adolescent circumcision on both in situ and
invasive penile cancer, there was a stronger association
with invasive disease (OR 0.53 vs. 0.91 in the Daling et al.
[23] paper and 0.41 vs. 1.0 in the Tseng et al. [24] paper)
(Table 1). However, a meta-regression of the ﬁve analyses
evaluating the effect of childhood/adolescent circumcision
compared to no circumcision revealed weak evidence that
the effect differed for in situ and invasive penile cancer
(p = 0.20), although power for this analysis was low
[14, 23, 24].
The role of phimosis in the association
between circumcision and penile cancer
To examine the association of circumcision with penile
cancer beyond the effect mediated through phimosis, two
papers stratiﬁed analyses by history of phimosis [23, 24].
Both of these found an association of circumcision with
invasive penile cancer among all subjects, but no evidence
of an association among those with no history of phimosis
(Table 3).
Discussion
Circumcision in childhood/adolescence was protective
against invasive penile cancer, with a summary odds ratio
of 0.33 (95% CI 0.13–0.83). Although there was some
evidence of heterogeneity (p = 0.11, I
2 = 55%), all three
studies demonstrated a protective effect (ORs 0.07, 0.41
and 0.53, respectively). In contrast, there was some evi-
dence that the risk of invasive penile cancer was elevated
among men circumcised mostly as adults. There was little
evidence of an association of circumcision at any age with
PIN or in situ penile cancer.
Quality of studies
The overall risk of bias across studies was high, with only
one study classiﬁed with no quality domains at high risk of
bias [27]. Only two studies were conﬁned to incident cases
due to the rarity of penile cancer and in the studies which
included at least some prevalent cases, risk of length
(survival) bias was considered to be high. It is possible that
the effect of circumcision may be different in the excluded
cases; the effect of circumcision appears to be greater on
invasive compared to PIN/in situ penile cancer and thus
studies including prevalent cases could underestimate the
true effect of circumcision on penile cancer. Speciﬁcally in
analyses of childhood/adolescent circumcision and inva-
sive cancer, all three included studies had a high risk of
length bias. It is therefore possible that the summary odds
ratio is an underestimate of the true effect.
Given the difﬁculties of conducting studies on penile
cancer, the following could be considered in future studies
to limit potential biases. Considering the rarity of penile
cancer, multi-centre international case–control studies are
the most feasible study design. However, prospectively
ascertaining incident penile cancer cases to enrol in case–
control studies will be the most effective method to limit
Table 3 Effect of circumcision on invasive penile cancer by history of phimosis
First author Study design Age at circumcision Comparison group Adjusted OR (95% CI)
All subjects Subjects with no history of
phimosis
Daling [23] Case control \10 years Not circumcised in childhood
a 0.43 (0.24, 0.77) 2.0 (0.59, 10.0)
b
Tseng [24] Matched case control \1 year Never circumcised 0.41 (0.13, 1.1) 0.79 (0.29, 2.6)
c
a Not circumcised in childhood (\10 years old) but those circumcised later in life are included
b A history of phimosis was only reported among those not circumcised in childhood (C10 years); among these children 254/278 controls had no
history of phimosis and 20/39 cases of invasive cancer had no history of phimosis. Speciﬁc information on the numbers included in this analysis
was not stated in the paper
c The analysis among those with no history of phimosis comprised all 44 participants who were circumcised at\1 year old and 61/83 of the
uncircumcised participants
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123length bias and could help to increase participation. Cir-
cumcision status should ideally be conﬁrmed by a clinician.
Finally, age at circumcision must be collected to allow the
temporality between circumcision and penile cancer to be
ascertained.
Effect of circumcision on in situ versus invasive penile
cancer
Circumcision had a protective association with invasive
penile cancer but there was no evidence of an effect on
PIN/in situ. Two additional papers compared the preva-
lence of circumcision among cases of invasive penile
cancer compared to in situ cancer [25, 33]. In one, the OR
for invasive penile cancer (compared to in situ cancer) was
0.15 among men circumcised as newborns compared to
uncircumcised men (95% CI 0.02–0.66) [25]. In the second
paper, none of the eight cases of invasive penile cancer
were circumcised neonatally, whereas 46% of those cases
with PIN or in situ penile cancer were circumcised neo-
natally; all eight cases (100%) of invasive penile cancer
were circumcised as adults and 8% of in situ cases were
circumcised as adults [33].
There is evidence that some in situ cancers develop
along a different pathway compared to invasive cancers
[21, 22]. PIN/in situ penile cancer is a diverse group of
neoplasms ranging from the benign form of Bowenoid
papulosis to the more aggressive forms of Bowen’s disease
and erythroplasia of Queyrat [34] and these may have
differing potential to progress to invasive disease [35].
Similar observations have been made for vulvar cancer
where two distinct aetiologic pathways have been descri-
bed for basaloid/warty tumour and keratinizing tumours
[36]. In one study, a strong effect was observed on eryth-
roplasia of Queyrat (OR = 0.12, 95% CI 0.00–0.90,
n = 315) and Bowenoid papulosis cases (OR = 0.20, 95%
CI 0.04–0.69), although there was no evidence of an effect
on Bowen’s disease (OR = 0.54, 95% CI 0.01–10.58,
n = 308) [31]. Considering the possibility of different
developmental pathways for penile cancer, it is biologi-
cally plausible that circumcision has a different effect on
speciﬁc aetiological subtypes.
Circumcision may also lead to increased detection of
early stage penile cancers, for example if such tumours
tend to be located under the foreskin. This increased
ascertainment in circumcised men would mask a true
underlying effect of circumcision on PIN/in situ penile
cancer and may therefore explain the lack of effect on PIN/
in situ penile cancer observed in this review. Many penile
tumours occur on the foreskin, and circumcision may exert
an effect partially by removing a site susceptible to
development of tumours.
Circumcision and phimosis
Phimosis is one of the strongest risk factors for penile
cancer and four papers evaluated the association between
phimosis and penile cancer (OR range 4.9–37.2 [23, 24, 27,
28]). The effect of childhood/adolescent circumcision on
invasive penile cancer may be largely mediated through
elimination of phimosis, since there was no evidence of an
association of circumcision with invasive disease when
analyses were restricted to individuals with no history of
phimosis [23, 24]. These results should be interpreted
cautiously; they were secondary analyses among a sub-
sample of the study populations and it is possible that they
were underpowered. However, this is biologically plausible
as circumcision eliminates risk of phimosis, and phimosis
is likely to lead a build up of smegma and repeated
inﬂammations, which may in turn lead to an increased risk
of penile cancer [17]. Phimosis is a stronger risk factor for
invasive disease compared to in situ cancer [23, 24] which
further supports the argument that circumcision acts
through prevention of phimosis and that some in situ
cancers develop through a different pathway to invasive
cancer.
Circumcision in adulthood
One possible reason for the increased risk of invasive
penile cancer among men circumcised mostly as adults
may be reverse causality: the surgery may have been per-
formed as a treatment for penile cancer, a cancer precursor,
or to treat an underlying medical condition known to be a
risk factor for penile cancer (foreskin tightness, phimosis,
or inﬂammation of the foreskin). Indeed in one study, all
identiﬁed circumcisions were performed at older ages due
to a medical indication, and although these were performed
[5 years prior to the reference date [27], this may explain
the signiﬁcantly elevated risk for invasive cancer among
circumcised men (OR = 14.87).
Circumcision and penile HPV infection
Unlike cervical cancer, evidence suggests that HPV
infection is not a necessary cause of penile cancer, with
HPV prevalence ranging between 15 and 71% among
penile cancer cases [21]. One paper measured HPV DNA
in tumour tissue [23] and there was some suggestion of a
greater protective association of childhood/adolescent cir-
cumcision with HPV negative tumours than HPV positive
tumours although the CIs around these estimates were wide
and overlapping (OR = 0.48, 95% CI 0.17–1.43 vs.
OR = 0.83, 95% CI 0.45–1.43). This association may be
due to chance, and contrasts with evidence from systematic
reviews [37] which showed circumcision is protective
1108 Cancer Causes Control (2011) 22:1097–1110
123against HPV prevalence, and perhaps also against persis-
tent [38] HPV infection in men. However, it may also
reﬂect that HPV is more commonly associated with in situ
tumours than invasive tumours [23], and the greater effect
of circumcision on invasive rather than in situ tumours. An
alternative explanation, is that HPV–PCR is compromised
in penile cancer samples taken at later stages of disease due
to tissue necrosis, and invasive penile cancer is in fact
HPV-associated [39].
Potential impact in the scale up of circumcision
services
In the two studies in the USA that calculated an adjusted
OR, assuming that childhood/adolescent circumcision is
causally related to invasive penile cancer, the population
attributable fractions were 27% [23] and 50% [24], sug-
gesting that a considerable proportion of cases were due to
a lack of circumcision in these populations. Circumcision
prevalence is relatively high in the United States and it is
quite likely a greater proportion of cases could be averted
in countries with a lower prevalence of circumcision. For
example in Swaziland, where circumcision is not com-
monly practised and penile cancer incidence is compara-
tively high (3.2 cases per 100,000 pyr [2, 3]), a national
strategy exists to increase circumcision prevalence to 80%
among HIV negative males aged 15–24 and to 33% among
male neonates as part of an HIV prevention strategy [40].
Successful implementation of this strategy may therefore
lead to a considerable reduction in the incidence of penile
cancer as well as HIV.
Conclusions
These data suggest that childhood/adolescent circumcision
is protective against invasive penile cancer. This effect
could be mediated partly through an effect on phimosis.
Circumcision services among adults are currently being
expanded as an HIV prevention strategy [20] and neonatal/
infant circumcision is emerging as a cost-effective long-
term HIV prevention strategy [41]. Some countries in sub-
Saharan Africa experience considerably higher incidence
of penile cancer compared to Western countries and
expansion of circumcision services in this region provides
an opportunity to reduce penile cancer as well as HIV in
men.
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